The role of the inherited disorders of hemoglobin, the first "molecular diseases," in the future of human genetics

Annual Review of Genomics and Human Genetics

Volumn 14, Issue , 2013, Pages 1-24

  Weatherall, David J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Global health burden; Hemoglobinopathy; Phenotypic diversity; Sickle cell anemia; Thalassemia

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F;

DEVELOPING COUNTRY; DNA DETERMINATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN GENETICS; IRON METABOLISM; LOWEST INCOME GROUP; MEDICAL GENETICS; PHENOTYPE; POPULATION BIOLOGY; POPULATION GENETICS; PROTEIN SYNTHESIS; REVIEW; SICKLE CELL ANEMIA; SOMATIC GENE THERAPY; STEM CELL TRANSPLANTATION; THALASSEMIA;

GENETICS, MEDICAL; GENETICS, POPULATION; HEMOGLOBINOPATHIES; HEMOGLOBINS; HUMANS;

EID: 84884297091     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-091212-153500     Document Type: Review

References (120)

1. Allen A, Fisher C, Premawardena A, Bandara D, Perera A, et al. 2012. Methemoglobinemia and ascorbate deficiency in hemoglobin E βthalassemia: Metabolic and clinical implications. Blood 120:2939-44
2. Allen A, Fisher C, Premawardena A, Peto T, Allen S, et al. 2010. Adaptation to anemia in hemoglobin E-βthalassemia. Blood 116:5368-70
3. Allen SJ, O'Donnell A, Alexander ND E, Alpers MP, Peto TE A, et al. 1997. a+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc. Natl. Acad. Sci. USA 94:14736-41
4. Allison AC. 1954. Protection afforded by sickle-cell trait against subtertian malarial infection. Br. Med. J. 1954(4587):290-94
5. Alter BP. 1990. Antenatal diagnosis: Summary of results. Ann. N. Y. Acad. Sci. 612:237-50
6. Alter BP, Modell CB, Fairweather D, Hobbins JC, Mahoney MJ, et al. 1976. Prenatal diagnosis of hemoglobinopathies: A review of 15 cases. N. Engl. J. Med. 295:1437-43
7. Angelini V. 1937. Primi risultati di ricerche ematologiche nei familiari di ammalati di anemia di Cooley. Minerva Med. 28:331-32
8. Antonarakis SE, BoehmC D, Giardina PV J, KazazianHH.1982. Nonrandom association of polymorphic restriction sites in the β-globin gene complex. Proc. Natl. Acad. Sci. USA 79:137-41
9. Baglioni C. 1962. The fusion of two peptide chains in hemoglobin Lepore and its interpretation as a genetic deletion. Proc. Natl. Acad. Sci. USA 48:1880-86
10. Bank A, Marks PA. 1966. Excess a chain synthesis relative to β chain synthesis in thalassaemia major and minor. Nature 212:1198-200
11. Bannerman RM. 1961. Thalassemia: A Survey of Some Aspects. New York: Grune and Stratton
12. Bauer DE, Kamran SC, Orkin SH. 2012. Reawakening fetal hemoglobin: Prospects for new therapies for the β-globin disorders. Blood 120:2945-53
13. Benz EJ, Forget BG. 1971. Defect in messenger RNA for human hemoglobin synthesis in beta thalassemia. J. Clin. Investig. 50:2755-60
14. Borg J, Patrinos GP, Felice AE, Philipsen S. 2011. Erythroid phenotypes associated with KLF1 mutations. Haematologica 96:635-38
15. Burka ER, Marks PA. 1963. Ribosomes active in protein synthesis in human reticulocytes: A defect in thalassaemia major. Nature 199:706-7
16. Caminopetros J. 1938. Recherches sur l'anémia é rythroblastique infantile des peuples De La Mediterranée orientale.Etude anthropologiqu e, étiologique et pathogénique.La transmission hereditaire De Lamaladia. Ann. Méd. 43:104-25
17. Chang H, Modell CB, Alter BP, Dickinson MJ, Frigoletto FD, et al. 1975. Expression of the β-Thalassemia gene in the first trimester fetus. Proc. Natl. Acad. Sci. USA 72:3633-37
18. Chang JC, Kan YW. 1979. β0 thalassemi a, a nonsense mutation in man. Proc. Natl. Acad. Sci. USA 76:2886-89
19. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, et al. 1995. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332:1317-22
20. Chini V, Valeri CM. 1949. Mediterranean hemopathic syndromes. Blood 4:989-1013
21. Clegg JB, Weatherall DJ. 1967. Haemoglobin synthesis in a-Thalassaemia (haemoglobin H disease). Nature 215:1241-43
22. Clegg JB, Weatherall DJ, Milner PF. 1971. HaemoglobinConstant Spring-A chain terminationmutant? Nature 234:337-40
23. Clegg JB, Weatherall DJ, Na-Nakorn S, Wasi P. 1968. Haemoglobin synthesis inβ-Thalassaemia. Nature 220:664-68
24. Colah R, Gorakshakar A, Phanasgaonkar S, D'souza E, Nadkarni A, et al. 2010. Epidemiology of β-Thalassaemia in Western India: Mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat. Br. J. Haematol. 149:739-47
25. Cooley TB, Lee P. 1925. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans. Am. Pediatr. Soc. 37:29
26. De Silva S, Fisher CA, Premawardhena A, Lamabadusuriya SP, Peto TE, et al. 2000. Thalassaemia in Sri Lanka: Implications for the future health burden of Asian populations. Lancet 355:786-91
27. Dintzis HM. 1961. Assembly of the peptide chains of hemoglobin. Proc. Natl. Acad. Sci. USA 47:247-50
28. EatonWA. 2003. Linus Pauling and sickle cell disease. Biophys. Chem. 100:109-16
29. Embury SH, Lebo RV, Dozy AM, Kan YW. 1979. Organization of the a-globin genes in the Chinese a-Thalassemia syndromes. J. Clin. Investig. 63:1307-10
30. Embury SH, Miller JA, Dozy AM, Kan YW, Chan V, Todd D. 1980. Two different molecular organizations account for the single a-globin gene of the a-Thalassemia-2 genotype. J. Clin. Investig. 66:1319-25
31. Fisher CA, Premawardhena A, De Silva S, Perera G, Rajapaksa S, et al. 2003. The molecular basis for the thalassaemias in Sri Lanka. Br. J. Haematol. 121:662-71
32. Forget BG, Baltimore D, Benz EJ, Housman D, Lebowitz P, et al. 1974. Globin messenger RNA in the thalassemia syndromes. Ann. N. Y. Acad. Sci. 232:76-87
33. Fucharoen S, Weatherall DJ. 2012. The hemoglobin E thalassemias. Cold Spring Harb. Perspect. Med. 2:A011734
34. Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G. 2010. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat. Genet. 42:1049-51
35. Garrod AE. 1909. Inborn Errors of Metabolism: The Croonian Lectures Delivered Before the Royal College of Physicians in Londo n, in Jun e, 1908. London: Henry Frowde and Hodder & Stoughton
36. Gerald PS, Diamond LK. 1958. The diagnosis of thalassemia trait by starch block electrophoresis of the hemoglobin. Blood 13:61-69
37. Gibbons RJ. 2012.a-Thalassemi a, mental retardatio n, andmyelodysplastic syndrome. Cold Spring Harb. Perspect. Med. 2:A011759
38. Gouagna LC, Bancone G, Yao F, Yameogo B, Dabire KR, et al. 2010. Genetic variation in human HBB is associated with Plasmodium falciparum transmission. Nat. Genet. 42:328-31
39. Haldane JBS. 1949. The rate of mutation of human genes. Hereditas 35(Suppl.):267-73
40. Haverfield EV, McKenzie CA, Forrester T, Bouzekri N, Harding R, et al. 2005. UGT1A1 variation and gallstone formation in sickle cell disease. Blood 105:968-72
41. Hebbel RP, Schechter AN, Elion J. 2013. Pathophysiology of sickle cell disease. Cold Spring Harb. Perspect. Med. In press
42. Herrick JB. 1910. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch. Intern. Med. 6:517-21
43. Heywood JD, Karon M, Weissman S. 1964. Amino acids: Incorporation into a-And β-chains of hemoglobin by normal and thalassemic reticulocytes. Science 146:530-31
44. Higgs DR. 2013. The molecular basis of a-Thalassemia. Cold Spring Harb. Perspect. Med. 3:A011718
45. Hollan SR, Szelenyi JG, Brimhall G, Duerst M, Jones RT, et al. 1972. Multiple alpha chain loci for human haemoglobins: Hb J-Buda and Hb G-Pest. Nature 235:47-50
46. Houle D, Govindaraju DR, Omholt S. 2010. Phenomics: The next challenge. Nat. Rev. Genet. 11:855-66
47. Housman D, Forget BG, Skoultchi A, Benz EJ. 1973. Quantitative deficiency of chain specificmessenger ribonucleic acids in the thalassemia syndromes. Proc. Natl. Acad. Sci. USA 70:1809-13
48. Hunt JA, Lehmann H. 1959. Abnormal human haemoglobins: Haemoglobin Bart's: A foetal haemoglobin without achains. Nature 184:872-73
49. Ingram VM. 1956. Specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178:792-94
50. Ingram VM, Stretton AOW. 1959. Genetic basis of the thalassemia diseases. Nature 184:1903-9
51. Jones RT, Schroeder WA. 1963. Chemical characterization and subunit hybridization of human hemoglobin H and associated compounds. Biochemistry 2:1357-67
52. Kan YW, Dozy AM. 1978. Polymorphisms of DNA sequence adjacent to human β-globin structural gene: Relationship to sickle mutation. Proc. Natl. Acad. Sci. USA 75:5631-35
53. Kunkel HG, Ceppellini R, Müller-Eberhard U, Wolf J. 1957. Observations on the minor basic hemoglobin component in blood of normal individuals and patients with thalassemia. J. Clin. Investig. 36:1615-25
54. Lambotte-Legrand J, Lambotte-Legrand C. 1951. L'anémieà hématies falciformes chez l'enfant indigène du Bas-Congo. Ann. Soc. Belge Méd. Trop. 31:207-34
55. Lettre G. 2012. The search for genetic modifiers of disease severity in the β-hemoglobinopathies. Cold Spring Harb. Perspect. Med. 2:A015032
56. Lucarelli G, Giardini C, Baronciani D. 1995. Bone marrow transplantation in β-Thalassemia. Semin. Hematol. 32:297-303
57. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, et al. 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc.Natl. Acad. Sci. USA107:5967-71
58. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. N. Engl. J. Med. 295:302-4
59. Neel JV. 1949. Inheritance of sickle-cell anemia. Science 110:64-66
60. Neel JV. 1962. Diabetes mellitus: A thrifty genotype rendered detrimental by progress? Am. J. Hum. Genet. 14:353-62
61. Nienhuis AW, Anderson WF. 1971. Isolation and translation of hemoglobin messenger RNA from thalassemi a, sickle cell anemi a, and normal human reticulocytes. J. Clin. Investig. 50:2458-62
62. Nienhuis AW, Nathan DG. 2012. Pathophysiology and clinical manifestations of the β-Thalassemias. Cold Spring Harb. Perspect. Med. 2:A011726
63. Nienhuis AW, Persons DA. 2012. Development of gene therapy for thalassemia. Cold Spring Harb. Perspect. Med. 2:A011833
64. O'Donnell A, Premawardhena A, Arambepola M, Allen SJ, Peto TE, et al. 2007. Age-related changes in adaptation to severe anemia in childhood in developing countries. Proc. Natl. Acad. Sci. USA 104:9440-44
65. O'Donnell A, Premawardhena A, Arambepola M, Samaranayake R, Allen SJ, et al. 2009. Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc. Natl. Acad. Sci. USA 106:18716-21
66. Ohta Y, Yamaoka K, Sumida I, YanaseT. 1971. HaemoglobinMiyad a, aβ-Dfusion peptide (anti-Lepore) type discovered in a Japanese family. Nat. New Biol. 234:218-20
67. Old JM, Fitches A, Heath C, Thein SL, Weatherall DJ, et al. 1986. First-Trimester fetal diagnosis for haemoglobinopathy: Report on 200 cases. Lancet 328:763-67
68. Old JM, Proudfoot NJ, Wood WG, Longley JI, Clegg JB, Weatherall DJ. 1978. Characterization of β-globin mRNA in the β0 thalassemias. Cell 14:289-98
69. Old JM, Ward RHT, Petrou M, Karagozlu F, Modell B, Weatherall DJ. 1982. First-Trimester fetal diagnosis for haemoglobinopathies: Three cases. Lancet 320:1413-16
70. Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ. 2008. Studies in haemoglobin E beta-Thalassaemia. Br. J. Haematol. 141:388-97
71. Olivieri NF, Weatherall DJ. 2009. Clinical aspects of βthalassemia and related disorders. In Disorders of Hemoglobin, ed. MH Steinberg, BG Forget, DR Higgs, DJ Weatherall, pp. 357-416. Cambridge, UK: Cambridge Univ. Press. 2nd ed.
72. O'Riordan S, Hien TT, Miles K, Allen A, Quyen NN, et al. 2010. Large scale screening for haemoglobin disorders in southern Vietnam: Implications for avoidance andmanagement.Br. J. Haematol. 150:359-64
73. Orkin SH, Alter BP, Altay C, Mahoney MJ, Lazarus H, et al. 1978. Application of endonucleasemapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N. Engl. J. Med. 299:166-72
74. Orkin SH, KazazianHHJr, Antonarakis SE, Goff SC, BoehmCD, et al. 1982. Linkage ofβ-Thalassaemia mutations andβ-globin gene polymorphisms withDNApolymorphisms in humanβ-globin gene cluster. Nature 296:627-31
75. Orkin SH, Kazazian HH Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP. 1982. Abnormal RNA processing due to the exon mutation of βE-globin gene. Nature 300:768-69
76. Orkin SH, Old JM, Lazarus H, Altay C, Gurgey A, et al. 1979. The molecular basis of a-Thalassemias: Frequent occurrence of dysfunctional aloci among non-Asians with Hb H disease. Cell 17:33-43
77. Orkin SH, Old JM, Weatherall DJ, Nathan DG. 1979. Partial deletion of β-globin geneDNA in certain patients with β0-Thalassemia. Proc. Natl. Acad. Sci. USA 76:2400-4
78. Ottolenghi S, Lanyon WG, Paul J, Williamson R, Weatherall DJ, et al. 1974. The severe form of a thalassaemia is caused by a haemoglobin gene deletion. Nature 251:389-92
79. Pauling L, Itano HA, Singer SJ, Wells IG. 1949. Sickle cell anemia, amolecular disease. Science 110:543-48
80. Penman BS, Pybus OG, Weatherall DJ, Gupta S. 2009. Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean. Proc. Natl. Acad. Sci. USA 106:21242-46
81. Perutz MF, RossmanMG, Cullis AF, MuirheadH, Will G, NorthACT. 1960. Structure of haemoglobin. Nature 185:416-22
82. Polani PE. 1990. The Impact of Genetics on Medicine: The Harveian Oration Delivered at the Royal College of Physicians, 18th October 1988. London: R. Coll. Physicians. 86 pp.
83. Premawardhena A, Fisher CA, Fathiu F, De Silva S, Perera W, et al. 2001. Genetic determinants of jaundice and gallstones in haemoglobin E βthalassaemia. Lancet 357:1945-46
84. Premawardhena A, Fisher CA, Liu YT, Verma IC, De Silva S, et al. 2003. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol. Dis. 31:98-101
85. Premawardhena A, Fisher CA, Olivieri NF, De Silva S, Arambepola M, et al. 2005. Haemoglobin E β thalassaemia in Sri Lanka. Lancet 366:1467-70
86. Ranney HM. 2001. Hemoglobin: A historical perspective. In Disorders of Hemoglobin, ed. MH Steinberg, BG Forget, DR Higgs, RL Nagel, pp. 1-24. Cambridge, UK: Cambridge Univ. Press. 1st ed.
87. Sankaran VG, Nathan DG. 2010. Reversing the hemoglobin switch. N. Engl. J. Med. 363:2258-60
88. Seguin B, Hardy BJ, Singer PA, Daar AS. 2008. Genomic medicine and developing countries: Creating a room of their own. Nat. Rev. Genet. 9:487-93
89. Seguin B, Hardy BJ, Singer PA, Daar AS. 2008. Human genomic variation initiatives in emerging economies and developing countries. Nat. Rev. Genet. 9:S3-9
90. Silvestroni E, Bianco I 1946. Una nova entita nosologica: La malatia microdrepanocitica. Haematologica 29:453-88
91. Spritz RA, Jagadeeswaran P, Choudary PV, Biro PA, Elder JT, et al. 1981. Base substitution in an intervening sequence of a β+ thalassemic human globin gene. Proc. Natl. Acad. Sci. USA 78:2455-59
92. St Pierre T, Olivieri NF, Thayalasuthan V, Muraca G, Weatherall D, et al. 2011. Relationship between serum ferritin and liver iron concentration in hemoglobin E thalassemia. Haematologica 96:69
93. Sturgeon P, ItanoHA, ValentineWN. 1952. Chronic hemolytic anemia associated with thalassemia and sickling trait. Blood 7:350-57
94. Suresh S, Fisher C, Ayyub H, Premawardena A, Allen A, et al. 2013. Alpha thalassaemia and extended alpha globin genes in Sri Lanka. Blood Cells Mol. Dis. 50:93-98
95. Taylor JM, Dozy A, Kan YW, Varmus HE, Lie-Injo LE, et al. 1974. Genetic lesion in homozygous a-Thalassaemia (hydrops foetalis). Nature 251:392-93
96. Vecchio F 1946. Sulla resistenza della emoglobina alla denaturazione alcalina in alcune sindromi emopatiche. Pediatria 54:545-48
97. Vichinsky EP. 2013. Clinical manifestations ofa-Thalassemia. Cold Spring Harb. Perspect. Med. 3:A011742
98. Wasi P, Na-Nakorn S, Suingdumrong A. 1964. Haemoglobin H disease in Thailand: A genetical study. Nature 204:907-8
99. Weatherall DJ. 1963. Abnormal haemoglobins in the neonatal period and their relationship to thalassaemia. Br. J. Haematol. 9:265-77
100. Weatherall DJ. 2001. Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias. Nat. Rev. Genet. 2:245-55
101. Weatherall DJ. 2008. Genetic variation and susceptibility to infection: The red cell and malaria. Br. J. Haematol. 141:276-86
102. Weatherall DJ. 2010. The importance of micromapping the gene frequencies for the common inherited disorders of haemoglobin. Br. J. Haematol. 149:635-37
103. Weatherall DJ. 2010. The inherited diseases of hemoglobin are an emerging global health burden. Blood 115:4331-36
104. Weatherall DJ. 2010. Thalassaemia: The Biography. Oxford, UK: Oxford Univ. Press
105. Weatherall DJ. 2010. Thalassemia as a global health problem: Recent progress towards its control in the developing countries. Ann. N. Y. Acad. Sci. 1202:17-23
106. Weatherall DJ. 2011. The challenge of haemoglobinopathies in resource-poor countries.Br. J. Haematol. 154:736-44
107. Weatherall DJ, Clegg JB. 1969. Disordered globin synthesis in thalassemia. Ann. N. Y. Acad. Sci. 165:242-52
108. Weatherall DJ, Clegg JB. 1975. The achain termination mutants and their relationship to thalassaemia. Philos. Trans. R. Soc. Lond. B 271:411-55
109. Weatherall DJ, Clegg JB. 2001. The Thalassaemia Syndromes. Oxford: Blackwell Sci. 4th ed.
110. Weatherall DJ, Clegg JB, Boon WH. 1970. The haemoglobin constitution of infants with the haemoglobin Bart's hydrops foetalis syndrome. Br. J. Haematol. 18:357-67
111. Weatherall DJ, Clegg JB, NaughtonMA. 1965. Globin synthesis in thalassemia: An in vitro study. Nature 208:1061-65
112. Weatherall DJ, Higgs DR, Bunch C, Old JM, Hunt DM, et al. 1981. Hemoglobin H disease and mental retardation-A new syndrome or a remarkable coincidence? N. Engl. J. Med. 305:607-12
113. Weatherall DJ, Vella F. 1960. Thalassaemia in a Gurkha family. Br. Med. J. 1960(5187):1711-13
114. Westaway D, Williamson R. 1981. An intron nucleotide sequence variant in a cloned β+ thalassaemia globin gene. Nucleic Acids Res. 9:1777-88
115. Whipple GH, Bradford WL. 1932. Racial or familial anemia of children: Associated with fundamental disturbances of bone and pigment metabolism (Cooley-Von Jaksch). Am. J. Dis. Child. 44:336-65
116. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TEA, et al. 1996. High incidence of malaria in a-Thalassaemic children. Nature 383:522-25
117. WilliamsTN, MwangiTW, Wambua S, Peto TE, Weatherall DJ, et al. 2005. Negative epistasis between the malaria-protective effects of a+-Thalassemia and the sickle cell trait. Nat. Genet. 37:1253-57
118. Williams TN, Uyoga S, Macharia A, Ndila C, McAuley CF, et al. 2009. Bacteraemia in Kenyan children with sickle-cell anaemia: A retrospective cohort and case-control study. Lancet 374:1364-70
119. Williams TN, Weatherall DJ. 2012. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb. Perspect. Med. 2:A011692
120. World Health Organ. 2002. Genomics and World Health. Geneva:World Health Organ